GSK Hid Morning Sickness Drug's Birth Defect Risks: Suit

Law360, New York (October 25, 2011, 10:15 PM EDT) -- GlaxoSmithKline PLC and other pharmaceutical companies were hit with a suit Tuesday in Pennsylvania court alleging the companies and their predecessors negligently buried evidence showing the morning sickness drug thalidomide caused birth defects.

Thalidomide — which was developed by German company Gruenenthal GmbH, also named as a defendant — was never approved by the U.S. Food and Drug Administration, but the suit says as many as 2.5 million doses of the drug were distributed to more than 20,000 people, including pregnant women.

The complaint also names...
To view the full article, register now.